Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison

Summary Background Irreversible electroporation (IRE) as newer ablation modality has been introduced and its clinical niche is under investigation. At present just one IRE system has been approved for clinical use and is currently commercially available (NanoKnife® system). In 2014, the International Working Group on Image-Guided Tumor Ablation updated the recommendation about standardization of terms and reporting criteria for image-guided tumor ablation. The IRE method is not covered in detail. But the non-thermal IRE method and the NanoKnife System differ fundamentally from established ablations techniques, especially thermal approaches, e.g. radio frequency ablation (RFA). Material/Methods As numerous publications on IRE with varying terminology exist so far – with numbers continuously increasing – standardized terms and reporting criteria of IRE are needed urgently. The use of standardized terminology may then allow for a better inter-study comparison of the methodology applied as well as results achieved. Results Thus, the main objective of this document is to supplement the updated recommendation for image-guided tumor ablation by outlining a standardized set of terminology for the IRE procedure with the NanoKnife Sytem as well as address essential clinical and technical informations that should be provided when reporting on IRE tumor ablation. Conclusions We emphasize that the usage of all above recommended reporting criteria and terms can make IRE ablation reports comparable and provide treatment transparency to assess the current value of IRE and provide further development.

[1]  J. Cardella,et al.  Society of Interventional Radiology clinical practice guidelines. , 2003, Journal of vascular and interventional radiology : JVIR.

[2]  D. D. de Bruin,et al.  The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol , 2014, BMJ Open.

[3]  Robert C. G. Martin,et al.  Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation , 2014, BMC Cancer.

[4]  M. Lee,et al.  Terminology and Reporting Criteria for Radiofrequency Ablation of Tumors in the Scientific Literature: Systematic Review of Compliance with Reporting Standards , 2014, Korean journal of radiology.

[5]  C. Bassi,et al.  Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study , 2015, Digestive Surgery.

[6]  Robert C. G. Martin,et al.  Intra - operative Anesthesia Management in Patients Undergoing Surgical Irreversible Electroporation of the Pancreas, Liver, Kidney, and Retroperitoneal Tumors , 2015, Anesthesiology and pain medicine.

[7]  Ian A. Donaldson,et al.  A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT) , 2014, Contemporary clinical trials.

[8]  J. Köllermann,et al.  A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). , 2015, Contemporary clinical trials.

[9]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Journal of vascular and interventional radiology : JVIR.

[10]  H. Shimada,et al.  Micrometastatic colorectal cancer lesions in the liver , 1998, Surgery Today.

[11]  R. Lencioni,et al.  Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours , 2009, CardioVascular and Interventional Radiology.

[12]  Hirofumi Fujii,et al.  Radiologic measurements of tumor response to treatment: practical approaches and limitations. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[13]  Suyashree Bhonsle,et al.  Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy , 2015, The Prostate.

[14]  G. Narayanan,et al.  Vessel Patency Post Irreversible Electroporation , 2014, CardioVascular and Interventional Radiology.

[15]  T. Baère,et al.  Irreversible Electroporation (IRE) Fails to Demonstrate Efficacy in a Prospective Multicenter Phase II Trial on Lung Malignancies: The ALICE Trial , 2015, CardioVascular and Interventional Radiology.

[16]  M. Makuuchi,et al.  Scenario 1 : Complication After a Surgical Procedure Not Caused by a Surgeon , 2022 .